- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02432469
Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence (MISSION-2)
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
The aim of this study is to test the effectiveness of a smartphone based application (APP) on improvement of patients' adherence to medications after coronary artery bypass grafting.
DESIGN AND PROCEDURES The study is a randomized controlled trial, having a plan to recruit 1000 patients underwent coronary artery bypass grafting in 2015, and randomized to either the intervention group or the control group, to test the effectiveness of a smartphone based APP focusing on improving patients medication adherence. Patients randomized to the intervention group install the APP and are intervened by it. The patients randomized to control group receive usual care. The investigators follow up patients in both groups by face to face or telephone interview at 3-month and 6-month after randomization. The 6-month effects of the intervention are evaluated.
The APP contains education materials about secondary prevention of coronary artery disease, patients can surf and read easily. The APP also collects information on medication prescription by doctors, reminds patients at every time of taking medications, and asks for feedback at 8 pm everyday. The APP also pushes one patient-specific questionnaire with 10-15 questions weekly, to collect information about patients' medication adherence and self-administration on blood pressure, blood lipid, glucose, physical activity, diet and body weight. APP will push series of recommendations right after patients' finishing the questionnaire to help them improve secondary prevention.
The coordinators from participating sites interview patients at the baseline, 3-month and 6-month after the randomization, for information of medication adherence, major events and outcomes after coronary artery bypass grafting and quality of life. The primary outcome measure is the Chinese version of the 8-item Morisky medication adherence scale which has already been validated in Chinese population.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Chenfei Rao, MD
- Telefonnummer: +861088396356
- E-mail: raochenfeifuwai@126.com
Undersøgelse Kontakt Backup
- Navn: Junzhe Du, MD
- Telefonnummer: +8617801013899
- E-mail: djzlfia@163.com
Studiesteder
-
-
Beijing
-
Beijing, Beijing, Kina, 100037
- Rekruttering
- China National Center for Cardiovascular Diseases
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Underwent coronary artery bypass grafting in 2015
Exclusion Criteria:
- Does not use a smartphone
- Can not install the study specific APP into his/her smartphone
- Does not use 3 or more applications installed in his/her smartphone
- Is incapable to understand texts in Chinese
- Can not type numbers in his/her smartphone
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Ingen indgriben: Kontrolgruppe
Sædvanlig pleje
|
|
Eksperimentel: Intervention group
APP specific for this study, with reminder, education materials and feedback mechanism for improving secondary medications
|
The APP contains education materials about secondary intervention of coronary artery disease, patients can surf and read them very easily.
The APP also collects information on medication prescription by doctors, reminds patients at every time of taking medications, and asks for feedback from patients at 8 pm every day.
The APP also pushes a patient-specific questionnaire with 10-15 questions weekly, to collect information about patients' medication adherence and self-management on blood pressure, blood lipid, blood glucose, physical activity, diet and body weight.
APP pushes series of recommendations right after patients' finishing the questionnaire to help them improve their secondary prevention.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Medication adherence measured by Chinese version of the 8-item Morisky medication adherence scale (C-MMAC-8)
Tidsramme: 6 months
|
patients' medication adherence measured by C-MMAC-8 at 6-month after randomization, the scale of more than 7 is defined as adherence to medications
|
6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Medication adherence measured by C-MMAC-8
Tidsramme: 3 month
|
patients' medication adherence measured by C-MMAC-8 at 3-month after randomization, the scale of more than 7 is defined as adherence to medications
|
3 month
|
mortality at 6-month
Tidsramme: 6 months
|
6 months
|
|
mortality at 3-month
Tidsramme: 3 months
|
3 months
|
|
rate of major adverse cardiovascular or cerebral events at 6-month
Tidsramme: 6 months
|
composite endpoint of all-cause death, myocardial infraction, stroke and repeat revascularization
|
6 months
|
rate of major adverse cardiovascular or cerebral events at 3-month
Tidsramme: 3 months
|
composite endpoint of all-cause death, myocardial infraction, stroke and repeat revascularization
|
3 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
pill count
Tidsramme: 6 months
|
the number of tablets remaining divided by the number of tablets prescribed
|
6 months
|
pill count
Tidsramme: 3 month
|
the number of tablets remaining divided by the number of tablets prescribed
|
3 month
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studieleder: Shengshou Hu, MD, PhD, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
- Ledende efterforsker: Zhe Zheng, MD, PhD, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
Publikationer og nyttige links
Generelle publikationer
- Yan J, You LM, Yang Q, Liu B, Jin S, Zhou J, Lin C, Morisky DE. Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients. J Eval Clin Pract. 2014 Aug;20(4):311-7. doi: 10.1111/jep.12125. Epub 2014 May 10.
- Yu C, Liu C, Du J, Liu H, Zhang H, Zhao Y, Yang L, Li X, Li J, Wang J, Wang H, Liu Z, Rao C, Zheng Z; MISSION-2 Collaborative Group. Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization. Am Heart J. 2020 Oct;228:17-26. doi: 10.1016/j.ahj.2020.06.019. Epub 2020 Jul 4.
- Liu CY, Du JZ, Rao CF, Zhang H, Liu HN, Zhao Y, Yang LM, Li X, Li J, Wang J, Wang HS, Liu ZG, Cheng ZY, Zheng Z. Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence (MISSION-2). Chin Med J (Engl). 2018 Jun 20;131(12):1480-1489. doi: 10.4103/0366-6999.233767.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- MOST-2013BAI09B01-3
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med APP intervention
-
Chang Gung UniversityChang Gung Memorial HospitalRekruttering
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityAktiv, ikke rekrutterende
-
Kent State UniversitySumma Health SystemUkendtPost-intensiv afdelings syndromForenede Stater
-
The University of Texas Health Science Center at...National Cancer Institute (NCI); Wake Forest University Health Sciences; Arizona... og andre samarbejdspartnereRekrutteringDepression | Betændelse | Kræft | Træthed | Angst | SøvnforstyrrelserForenede Stater
-
The University of Hong KongAfsluttet
-
Ksana HealthNovo Nordisk A/SAfsluttetFedme | Overvægtig | Psykisk lidelseForenede Stater
-
Rubén Martín PayoRekruttering
-
Louisiana State University Health Sciences Center...University of VirginiaRekrutteringSeksuelt overførte sygdomme | STI | Præ-eksponeringsprofylakseForenede Stater
-
Fundació d'investigació Sanitària de les Illes...Hospital Son Espases; Fundació Institut de Recerca de l'Hospital de la... og andre samarbejdspartnereAfsluttetDepression | Angstlidelser | Brænde ud | Psykisk lidelse | Post traumatisk stress syndromSpanien
-
Hospital Universitario Virgen MacarenaUkendt